Skip to content

Assessment effect of replacement liquid (crystalloid and colloid ) used for deairing circuits of cardiopulmonary bypass by patient own blood in patient undergoing coronary artery bypass grafting on clinical outcome

Assessment Effect of retrograde autologous priming on clinical outcome of heart lung bypassing on patients undergoing coronary artery bypass grafting

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016073029123N1
Enrollment
80
Registered
2016-10-11
Start date
2016-10-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary artery disease. Ischaemic heart diseases

Interventions

Intervention 1: In the intervention group before the start of cardiopulmonary bypass and After the arterial cannulation by the surgeon we allow the patient blood reversely enter in arterial line by ao
Treatment - Other
Treatment - Drugs
In the intervention group before the start of cardiopulmonary bypass and After the arterial cannulation by the surgeon we allow the patient blood reversely enter in arterial line by aorta pressure And
In the control group cardiopulmonary bypass circuits primed with conventional method (approximately1500 ml of crystalloid and colloid).And this fluid volume remains in the cardiopulmonary bypass circu

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: adult patients undergoing coronary artery bypass surgery using cardiopulmonary bypass; no history of past heart surgery; age older than 18 and less than 70 years old; hemoglobin level greater than 8.5 and less than 14; body weight more than 45 kg and less than 100 kg; left ventricular ejection fraction greater than 25%. Exclusion criteria: history of cardiac surgery; the patient or the patient's family withdraw from the study during the intervention period; emergency surgery; severe infection; clotting problems before surgery (INR> 1.2, aPTT> 40 s and blood platelet count less than 100 thousand per cubic meter); danapyroid and Lepyrudyn and dabigatran drug in the month before the operation; use Hemofilter and Cell Saver; the use of preoperative mechanical ventilation; dialysis before surgery; the existence of liver failure as (AST> 40 unit / L) and ((ALT> 40 unit / L before surgery.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Changes in arterial blood gases. Timepoint: Before anesthesia, intraoperative and postoperative. Method of measurement: content of each gas in arterial blood Under the pressure of eac gas.;The need for blood and blood products transfusions during surgery. Timepoint: During Surgery. Method of measurement: The number of bags of blood and blood products in terms of unit.;The amount of postoperative blood and blood product transfusion. Timepoint: After surgery and during the hospitalization. Method of measurement: The number of bags of blood and blood products.;Duration of mechanical ventilation connection. Timepoint: During the intensive care unit. Method of measurement: Duration of mechanical ventilation connection based on hours.;Ejection fraction. Timepoint: After surgery in ward. Method of measurement: Ratio between strok volume to end diastolic volume according to percent.

Secondary

MeasureTime frame
Hemoglobin - Hematocrit. Timepoint: During the operation, 12,24 and 48 hours after surgery. Method of measurement: The amount of hemoglobin according to milligrams per deciliter and hematocrit according percent.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMusa Rafiee Vardanjany

Iran University of Medical Sciences

musa rafiee7@gmail.com+98 21 8888 2886

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026